Home Blog Page 1634

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

By
Advertorial Desk
-

SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current therapies

These are the first global Phase 3 studies of a long-acting anti-TSLP antibody, marking a pivotal step as GB-0895 advances the promise of programmable biology

SOMERVILLE, Mass., Dec. 1, 2025 /PRNewswire/ — Generate:Biomedicines (“Generate”) today announced it plans to initiate two global Phase 3 clinical trials, SOLAIRIA-1 and SOLAIRIA-2, evaluating GB-0895 in approximately 1,600 adults and adolescents with severe asthma whose disease remains inadequately managed on current therapies. GB-0895 is an investigational, long-acting monoclonal antibody engineered with AI to target thymic stromal lymphopoietin (TSLP), a key driver of airway inflammation. These studies will evaluate the efficacy of GB-0895 in reducing clinically significant asthma exacerbations over 52 weeks, the primary objective for both trials.

GB-0895 is an antibody optimized using AI to achieve ultra-high-affinity TSLP binding, extended half-life, and high specificity. It is being developed as a long-acting therapy designed for dosing every six months to help reduce the treatment burden for people with severe asthma. GB-0895 is also being evaluated in a Phase 1 clinical trial in chronic obstructive pulmonary disease (COPD).

“Advancing GB-0895 into Phase 3 marks an important milestone for Generate and for the field,” said Mike Nally, chief executive officer of Generate:Biomedicines. “It demonstrates the potential of programmable biology to design optimal molecular solutions for patients with unprecedented speed and intentionality — in this instance, showing how an antibody engineered with AI can achieve a potentially best-in-class profile and advance into Phase 3 studies within just four years.”

“Despite significant advances in respiratory medicine, severe asthma remains difficult to control for many people,” said Laurie Lee, MD, chief medical officer for immunology & inflammation at Generate:Biomedicines. “Initiating Phase 3 studies for GB-0895 reflects both our commitment to people living with severe asthma and the strength of our platform to bring forward medicines that could reduce the burden of chronic respiratory disease.”

Phase 1 Results Presented at ERS 2025
Dave Singh, MD, professor of clinical pharmacology and respiratory medicine at the University of Manchester and medical director at the Medicines Evaluation Unit, presented Phase 1 data for GB-0895 at the European Respiratory Society (ERS) International Congress 2025 in Amsterdam. In this study of 96 people with mild to moderate asthma, GB-0895 was generally well tolerated across a wide dose range (10 mg to 1,200 mg), demonstrated dose-proportional pharmacokinetics with an approximately 89-day half-life, and produced sustained reductions in key biomarkers consistent with blocking TSLP for at least six months. These data support the six-month dosing schedule now being evaluated in the Phase 3 SOLAIRIA program. The full presentation from ERS is available on Generate’s website.

About SOLAIRIA
The Phase 3 development program for GB-0895 includes two global clinical trials, SOLAIRIA-1 and SOLAIRIA-2, enrolling approximately 1,600 patients with severe asthma across more than 40 countries in North America, Europe, Latin America, and Asia Pacific. Each trial will evaluate GB-0895 (300 mg subcutaneous every six months) versus placebo over 52 weeks, with a primary endpoint of reduction in annualized asthma exacerbation rate and additional assessments of lung function, symptom control, and quality of life. These replicate studies share nearly identical designs but differ slightly in geographic distribution to ensure robust data across diverse populations. More information is available at www.solairia.com.

About GB-0895
GB-0895 was designed with Generate’s generative biology platform, which integrates proprietary machine-learning models with high-throughput experimentation. GB-0895 was engineered to block TSLP, an epithelial cell-derived cytokine that helps initiate and amplify airway inflammation in asthma. Using a generative optimization technology stack, GB-0895 was computationally designed to improve potency and half-life while retaining specificity. A mechanism-of-action animation can be viewed on Generate’s website. Patent No. 12,110,324 has been issued by the U.S. Patent and Trademark Office.

About Generate:Biomedicines
Generate is a technology company founded at the intersection of machine learning, biological engineering, and medicine that is advancing a new era of programmable biology to engineer better medicines for patients, faster. The Generate Platform’s infusion of technology into biology allows us to address historically undruggable and hard-to-drug targets as well as known targets in new and more effective ways. The platform has enabled the generation of a broad pipeline of therapies across multiple therapeutic areas and protein-based modalities, addressing health challenges out of reach of traditional approaches. Founded by Flagship Pioneering in 2018, Generate is a clinical-stage company leading a fundamental shift from drug discovery to drug generation. Learn more at www.generatebiomedicines.com or follow us on X, LinkedIn, and YouTube. 

Generate Media Contact
Megan McLaughlin
pr@generatebiomedicines.com

 

EP YAYING Marks Three Years in the U.S., Weaving Cultural Connection Through Eastern Elegance

By
Advertorial Desk
-

NEW YORK, Dec. 1, 2025 /PRNewswire/ — This month, EP YAYING, the acclaimed Chinese high-end fashion house, celebrates the third anniversary of its boutique at the American Dream Mall in New Jersey. Since its debut in December 2022, the brand has captivated the international fashion scene by masterfully uniting Eastern aesthetics with contemporary design, delivering collections that are as elegant as they are wearable. Renowned for its impeccable craftsmanship and premium materials, EP YAYING has steadily built a devoted following among discerning American clients.

Designed by French architect Franklin Azzi, the boutique embodies a theme of “Dialogue and Balance.” Within a clean, minimalist space, subtle elements such as natural jade and inspirations drawn from traditional Chinese embroidery create a serene and sophisticated atmosphere—bridging heritage and modernity with quiet confidence. As the only high-end Chinese fashion brand in The Avenue luxury wing of American Dream Mall, EP YAYING stands proudly among global icons such as Hermès and Louis Vuitton, enriching the retail landscape with a unique cultural perspective.

Throughout the past three years, EP YAYING has deepened its relationship with U.S. customers through curated private events and personalized services. A longtime client, who has worn the brand for over two decades, remarked, “From business meetings to holiday celebrations, EP YAYING has been with me during life’s most meaningful moments. I admire the exquisite fabrics and craftsmanship—but even more, the graceful flow of each design connects me to a rich cultural heritage, offering a sense of refined individuality.” This profound emotional resonance has become central to the brand’s identity and sustained growth overseas.

Looking forward, EP YAYING remains committed to global expansion under the guiding principles of “Balance, Love, and Happiness.” Future collections will continue to showcase rare materials sourced from China—including Alxa cashmere and plateau yak wool—along with artisanal patterns from its premium Blue Label line. These elements bring the quiet power and grace of Eastern aesthetics to the global stage, offering a unique proposition for sophisticated international consumers who value cultural depth, exceptional quality, and a distinct point of view.

MaxsMaking Inc. Addresses SEC Trading Suspension and Affirms Full Cooperation with Regulators

By
Advertorial Desk
-

SHANGHAI, Dec. 1, 2025 /PRNewswire/ — MaxsMaking Inc. (Nasdaq: MAMK) (“MaxsMaking” or the “Company”), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, addresses the ten-day Order of Suspension of Trading in the securities of the Company entered by the Securities and Exchange Commission (“SEC”) that expires tonight, December 1, 2025 at 11:59 PM Eastern Standard Time.

On November 14, 2025, the SEC entered the Order because of what appeared to the SEC to be the potential manipulation of the Company’s securities designed to artificially inflate the price and trading volume of the Company’s securities. The trading suspension did not relate to questions regarding the accuracy and adequacy of information in the marketplace about the Company. Moreover, the Company has no information to suggest that the trading involved any shares held by current MaxsMaking officers, directors, or employees. Similarly, the Company has no information at this time to suggest that the recent trading activity was conducted by persons known to current management.

The Company has pledged to and is cooperating fully with the SEC’s inquiry into the trading of the Company’s securities. The Company also is cooperating fully with related inquiries by other capital markets regulators, including responding to a request from Nasdaq Regulation for additional information. The Company stands fully behind the accuracy and content of all press releases that the Company has issued and its public filings, including its published financial statements.

The Company has not, does not and will not communicate with publishers of internet newsletters or internet chat boards. Moreover, the Company has not paid anyone and does not pay anyone to promote its securities. The Company’s retention of investor relations firms is solely for the purpose of ensuring prompt dissemination of material and financial information as required by regulators and establishing public awareness of corporate developments warranting disclosure. MaxsMaking refers all potential investors to warnings issued by the SEC about potentially misleading conduct in the promotion of stocks via the internet. Consistent with investor notices published by the SEC, MaxsMaking cautions potential investors who are interested in information about the Company to consider only information issued directly by the Company in filings with the SEC and press releases published by the Company.

In response and to advise the Company in connection with the trading suspension and the Company’s cooperation with regulators, the Company has hired Jacob Frenkel, Chair, Government Investigations and Securities Enforcement Practice, Dickinson Wright PLLC, to advise the Company. Mr. Frenkel, nationally recognized for defending and litigating trading suspensions, previously worked for the SEC’s Division of Enforcement, was a U.S. federal criminal prosecutor of public corruption and federal securities laws violations, and in his private practice has successfully litigated a trading suspension of an issuer’s securities such that the SEC set aside the trading suspension. Mr. Frenkel and Dickinson Wright PLLC will supplement and complement the efforts of Ellenoff Grossman & Schole LLP, which has represented and continues to represent the Company since its initial public offering.

Mr. Xiaozhong Lin, Chairman and Chief Executive Officer of MaxsMaking, remarked: “As I stated previously, we are proud of our successful Nasdaq IPO in July 2025. We are committed to continuing to build value for our shareholders. We do not condone improper trading activity in our securities, and we are pleased to have added an expert to our team to reassure securities regulators about our commitment to compliance with securities laws and regulations. We will support all legal efforts to pursue aggressively any persons who seek to harm the Company’s shareholders or impact artificially the value of the Company’s securities.”

The Company expressly disclaims any obligation in the future to address in public announcements or otherwise unusual patterns of trading in its securities or unusual prices or price swings thereof.

About MaxsMaking Inc.

Founded in 2007 and headquartered in Shanghai, MaxsMaking Inc. specializes in customized consumer goods with a focus on advanced technology and innovation. With production facilities in China’s Zhejiang and Henan provinces, the Company integrates digital production, software development, product design, brand management, online sales and international trade to deliver small-batch textile customization services. Its products include backpacks, shopping bags, aprons, and other promotional items. Using sustainable materials and proprietary order management technologies, MaxsMaking delivers high-quality, cost-effective products while emphasizing environmental protection and social responsibility. For more information, please visit the Company’s website: https://ir.maxsmaking.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.

For more information, please contact:

MaxsMaking Inc.
Investor Relations
Email: ir@maxsmaking.com

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

CN Energy Group. Inc. Announces Launch of PATHENBOT Robotics Solutions Platform and PATHENBOT’s Official Website

By
Advertorial Desk
-

LISHUI, China, Dec. 1, 2025 /PRNewswire/ — CN Energy Group. Inc. (“CNEY” or the “Company”) (NASDAQ: CNEY), a Nasdaq-listed company, today announced that its wholly owned subsidiary, PATHENBOT Group Inc. (“PATHENBOT”), has launched its robotics solutions platform and its official website (www.pathenbot.com). This launch represents the next step in the development of PATHENBOT’s intelligent robotics initiatives.

The North American intelligent automation market continues to see increased demand. PATHENBOT’s mission is to provide customizable intelligent robotics products and related automation services to small and medium-sized industrial, logistics, and catering businesses in North America. PATHENBOT intends to integrate robotics, software, and artificial intelligence technologies to provide automation solutions as part of the Company’s continued development.

Wenhua Liu, CEO of CNEY, commented: “We are pleased to announce the launch of PATHENBOT’s robotics solutions platform and official website, which reflect our continued efforts to advance the Company’s strategic initiatives and support our broader growth plans.“

About CN Energy Group. Inc.

CN Energy Group. Inc. is currently listed on NASDAQ under the symbol “CNEY.” With patented proprietary bioengineering and physiochemical technologies, CNEY has pioneered and specialized in producing high-quality recyclable activated carbon and renewable energy from abandoned forest and agricultural residues, converting harmful wastes into invaluable wealth and delivering significant financial, economic, environmental and ecologic benefits. CNEY’s products and services have been widely used by food and beverage producers, industrial and pharmaceutical manufacturers, as well as environmental protection enterprises. For more information, please visit the Company’s website at www.cneny.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that do not relate to historical facts but are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can generally (although not always) be identified by their use of terms and phrases such as anticipate, appear, believe, continue, could, estimate, expect, indicate, intend, may, plan, possible, predict, project, pursue, will, would and other similar terms and phrases, as well as the use of the future tense. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on current beliefs, expectations and assumptions regarding the future of the business of the Company, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control, including the risks described in our registration statements and annual reports under the heading “Risk Factors” as filed with the Securities and Exchange Commission. Actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Forward-looking statements in this press release speak only as of the date hereof. Unless otherwise required by law, we undertake no obligation to publicly update or revise these forward-looking statements, whether because of new information, future events or otherwise.

Information contained on, or that can be accessed through, the Company’s website or any other website or any social media is expressly not incorporated by reference into and is not a part of this press release.

Lee’s Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po

By
Advertorial Desk
-

HONG KONG, Dec. 1, 2025 /PRNewswire/ — Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group“, stock code: 0950.HK) expresses its deep condolences to the victims of the serious fire at Wang Fuk Court in Tai Po, which caused multiple casualties and left many residents homeless and in urgent need of assistance. The Group has made a donation of HK$200,000 to the “Support Fund for Wang Fuk Court in Tai Po” established by the HKSAR Government to render assistance to residents of Wang Fuk Court and support all relevant works.

As a pharmaceutical company listed in Hong Kong for over two decades, Lee’s Pharm deeply mourns the victims of the fire and extends heartfelt sympathy to those injured and the families affected. During this difficult time, the Group stands in solidarity with the people of Hong Kong, committing to support those impacted through concrete actions. We also call on all sectors of society to join hands in helping the victims overcome this hardship and rebuild confidence in their lives.

The Group also pays the highest tribute to the firefighters, medical staff, and volunteers who have worked tirelessly and bravely in the rescue efforts and expresses profound gratitude for their selfless dedication and perseverance.

About Lee’s Pharmaceutical Holdings Limited

Lee’s Pharm is a research-driven and market-oriented biopharmaceutical company with over 30 years of operation in the pharmaceutical industry in China. The company is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing based in Mainland China with global perspectives. Lee’s Pharm has established extensive partnerships with around 30 international companies and currently markets over 25 proprietary, generic, and licensed-in pharmaceutical products in Mainland China, Hong Kong, Macau, and Taiwan. The company focuses on several key disease therapeutic areas such as cardiovascular health, woman’s health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. For more information about Lee’s Pharm, please visit: www.leespharm.com.

 

Young Chinese revive, transform ancient crafts for modern markets

By
Advertorial Desk
-

DALI, CHINA – Media OutReach Newswire – 1 December 2025 – At the 2025 Intangible Cultural Heritage（ICH） brand promotion week held from Sunday to Friday in Dali, which was organized by the Ministry of Culture and Tourism, over 120 heritage brands demonstrated how traditional craftsmanship can be integrated with contemporary design.

Caption: A woman experiences the tie-dye technique of Bai ethnic groupin a dyehouse in Zhoucheng Village of Dali Bai Autonomous Prefecture, southwest China's Yunnan Province, Nov. 21, 2025.(Xinhua/Hu Chao)
Caption: A woman experiences the tie-dye technique of Bai ethnic groupin a dyehouse in Zhoucheng Village of Dali Bai Autonomous Prefecture, southwest China’s Yunnan Province, Nov. 21, 2025.(Xinhua/Hu Chao)

At the event’s opening ceremony, Douyin, the Chinese version of TikTok, announced that its e-commerce platform had sold 6.5 billion orders of ICH-related products in the past year. Meanwhile, another platform, Kuaishou, reported over 178 billion views for ICH-related videos.

In a sun-drenched courtyard in a village in southwest China’s Yunnan Province, Bai ethnic woman Yang Julan hung up newly dyed tie-dye scarves, one by one. Soon, the sun would dry them, allowing these scarves to embark on a journey to Europe, destined for the Netherlands.

A farmer near Erhai Lake in the city of Dali, Yang would possibly struggle to pinpoint Amsterdam on a world map, but her creations do find their way to the Dutch capital and even beyond — adorning customers in distant lands she has never seen.

“At my age, to see our dyeing cloth reach the world map… It’s a profound pride,” said Yang, 65.

The tie-dye technique, dating back nearly 2,000 years to the Eastern Han Dynasty (25-220), was listed as a national-level Intangible Cultural Heritage in China in 2006.

Like tie-dye, ICH in general is experiencing a remarkable revival in China — resulting in the transformation of ancient crafts into modern global commodities, driven by a new generation who are breathing contemporary life into time-honored traditions.

Just a few years ago, many traditions faced extinction as practitioners dwindled. Yang herself had abandoned her craft, believing “the ancestors’ handiwork had become useless.”

The turning point came when urban entrepreneurs recognized the commercial potential of ICH.

While working in Beijing, Dali native Zhang Hanmin, then 28, noticed urban youth embracing traditional elements like embroidery and prints in their clothes and accessories. Convinced that her hometown’s tie-dye held similar appeal, she returned to Dali to revitalize the craft.

Having established a brand named Dali Blue in 2012, Zhang focused on innovating product designs while also launching hands-on workshops for visitors — resulting in an influx of both orders and tourists.

Such market success created more jobs, attracting experienced local artisans like Yang back to the craft. “With improvements made by the young people, tie-dye has been reborn,” Yang noted.

This craft’s revival is part of the country’s larger wave of cultural entrepreneurship — seeing young Chinese tapping into ICH to build successful commercial ventures.

Chinese cultural authorities have established a comprehensive system to preserve and revitalize ICH items, guiding artisans to enhance quality, build brands and sharpen their market focus.

Caption: A staff member displays a Lord Rabbit, known as Tu'er Ye in Chinese (a traditional handicraft and a festive clay toy for children, especially in Beijing), during the 2025 Intangible Cultural Heritage (ICH) brand promotion week in Dali City, southwest China's Yunnan Province, Nov, 23,2025.(Xinhua/HuChao)
Caption: A staff member displays a Lord Rabbit, known as Tu’er Ye in Chinese (a traditional handicraft and a festive clay toy for children, especially in Beijing), during the 2025 Intangible Cultural Heritage (ICH) brand promotion week in Dali City, southwest China’s Yunnan Province, Nov, 23,2025.(Xinhua/HuChao)

Numerous people in their 40s, 30s and even 20s have joined ICH preservation and inheritance efforts, creating many distinctive heritage brands, the ministry revealed.

During the “Double 11” shopping festival earlier this month, ICH-related product sales via Alibaba’s Taobao platform had reached 9.42 billion yuan (1.33 billion U.S. dollars).

Brian Linden, an American from Chicago who has lived in Dali for over a decade, said growing cultural confidence is reshaping Chinese consumption patterns, making heritage products part of daily life.

“Meanwhile, these heritage goods, infused with Chinese aesthetics, are crossing borders and stirring a strong ‘China chic’ trend in the international market,” Linden added.

Hashtag: #IntangibleCulturalHeritage #CulturalHeritage #TieDye #BaiEthnicGroup #DaliYunnan #EthnicArts

The issuer is solely responsible for the content of this announcement.

GEEKOM Unveils GeekBook X14 Pro: The World’s First All-Metal Ultralight Laptop

By
Advertorial Desk
-

TAIPEI, Dec. 1, 2025 /PRNewswire/ — GEEKOM has officially announced the upcoming launch of its GeekBook X series, scheduled for mid-December 2025. Designed to balance portability and performance, the new lineup aims to elevate productivity, creative workflows, and everyday entertainment. Leading the charge is the GeekBook X14 Pro, which sets a new benchmark as the lightest Windows laptop in its class, redefining standards for mobile computing and professional efficiency.

Founded in Taiwan in 2003, GEEKOM has emerged as a formidable player in the premium mini PC market. In Q3 2025, the company recorded a remarkable 150% revenue growth over the previous quarter. Now expanding into the notebook segment, GEEKOM is positioning itself as a full-spectrum PC brand, encapsulated in its brand vision: “Think PC, Think GEEKOM.” The company now competes alongside global tech giants -yet in many European countries, GEEKOM‘s high-end mini PCs consistently outperform these rivals in popularity.

The GeekBook X series includes two models: the X14 Pro and the X16 Pro. Both are engineered for high-performance computing and seamless user experiences, featuring Intel’s latest Ultra processors for accelerated multitasking, a 120Hz high-refresh-rate display that delivers ultra-smooth visuals, and a sleek, skin-friendly full-metal chassis that combines lightweight durability with premium aesthetics.

As the more compact of the two, the GeekBook X14 Pro unites premium craftsmanship with cutting-edge performance in an ultra-portable form factor. Encased in a lightweight magnesium alloy chassis with a soft-touch finish, it weighs just 2.2 lbs, making it the lightest Windows laptop in its category. Its sleek profile measures only 16.9mm at its thinnest point, roughly the diameter of a standard ballpoint pen, ensuring effortless mobility. The 14-inch OLED display has a resolution of 2.8K and supports 120Hz refresh rate, delivering crisp, fluid visuals. With up to 16 hours of battery life, it’s built for all-day productivity and entertainment. Powered by the top-notch Intel Core Ultra 9 185H chip, the X14 Pro offers robust performance ideal for business professionals, content creators, and everyday users seeking a powerful yet travel-friendly device.

The GeekBook X14 Pro redefines what an ultralight laptop can be—sleek, premium and performance-driven. For users demanding the ultimate notebook experience, this device offers a compelling new option. Official release is set for mid-December 2025, please stay tuned.

Magic Chess: Go Go Season 4 and THE KING OF FIGHTERS collaboration goes live, road to GO1 World Championship kicks off

By
Advertorial Desk
-

THE KING OF FIGHTERS crossover marks MCGG’s first-ever collaboration

SINGAPORE – Media OutReach Newswire – 1 December 2025—Magic Chess: Go Go (MCGG) launched its fourth season, teaming up with THE KING OF FIGHTERS (KOF) for the game’s first collaboration. This milestone partnership brings the fighter universe to the chessboard with eight themed commander skins, two new synergies, and a KOF-inspired chessboard skin. In addition, players gain access to the Promo Diamonds event, new battle modes, and can fight their way to the top in the GO1 World Championship (GO1)—MCGG’s first international tournament. Developed by the international video game company, MOONTON Games, the new season demonstrates its commitment to creating engaging gaming and esports experiences worldwide.
Don your fighter gear in Season 4
MCGG kicks off its first-ever collaboration by joining forces with KOF—the legendary franchise that has inspired generations of gamers. The battlefield will be decked out in combat with eight all-new KOF-themed commander skins, featuring Aurora “Kula Diamond”, Chou “Iori Yagami”, Dyrroth “Chris”, Karina “Leona”, Guinevere “Athena Asamiya”, Gusion “K'”, Paquito “Terry Bogard”, and Valir “Kyo Kusanagi”. Be prepared to emerge a #FightersReborn as the collaboration unleashes two exclusive synergies, KOF and Mortal Rivals, alongside with a limited-time chessboard skin.
The collaboration also introduces the Destined Duel event, where players can earn up to 70 Leona Draw Tokens, KOF Deploy Effects, and the Johnson “Death Chariot” skin. Set in a retro arcade-inspired interface, Destined Duel immerses players in the classic fighting spirit of KOF. Players can also enjoy Promo Diamonds (in-game currency) to unlock generous discounts on in-game items. By participating in events, logging in, and more, players can collect commanders and chessboard skins to upgrade their battlefield experience.
Gao “Skyhook” Chong, MCGG Producer at MOONTON Games, said: “Working with KOF is a huge step for MCGG, and we’re especially excited since its our first collaboration. Bringing this iconic franchise into our universe allows us explore new ways to merge strategy and combat while offering players more depth and variety in how they approach the game. This is not just a crossover—it’s an expansion of our IP and a showcase of how our game can grow beyond auto chess while keeping strategic gameplay at its core. We’re excited to see how players from both worlds adapt, compete, and make the MCGG battlefield their own!”
Outfight, outsmart, dominate the chessboard
The new Commander Power Cards introduces a new layer of strategy to the battlefield. Each commander now wields unique powers, allowing players to experiment with devastating combinations. Players can select their own Commander’s Power Card for enhanced abilities or harness the strength of other Commanders for a unique advantage. Players can turn the tide of battle by picking the right cards at the right time—rewarding bold strategy and skill as they fight to dominate the chessboard.
Step into the new Arena Mode, where every player has unlimited time in the preparation round to build their ultimate lineup. Plan your strategy, position your commanders, and unleash deadly combinations to dominate the battlefield. The Arena Mode features an exclusive ranking system, where players’ ranks depend on the number of Arena Trophies. Win rounds, climb the leaderboard, and prove you have what it takes to be the top fighter!
As the rounds progress, Commanders level up automatically and players receive random Go Go Cards and powerful Equipment to strengthen their forces. They can also purchase game-changing items from the Arena Shop to earn an edge in fights. Before each duel, engage in the high-stakes Betting Mechanism—double your trophies for massive rewards, but beware as one wrong move could cost you heavily.

Fight to become the first MCGG world champion
MCGG Season 4 returns with the MCGG Rising Star (MRS), offering 14 direct slots to the upcoming GO1. The inaugural edition of MCGG’s most prestigious international tournament will take place alongside the M7 World Championship (M7) in Jakarta, Indonesia, in January 2026. As part of the M7 Carnival, MCGG will join Mobile Legends: Bang Bang (MLBB) in turning Indonesia into a global sporting stage, uniting top teams, players, and fans from around the world in a celebration of esports.
With its democratic and accessible gameplay, MCGG makes it possible for any player to compete at the highest level. By empowering all players to rise as champions, MCGG brings its vision of inclusive esports onto the international stage. The title will make history at the 33rd Southeast Asian (SEA) Games in Bangkok, Thailand, marking the first time a mobile auto chess game will feature at the biennial regional sporting event. On 12 December, the MCGG demonstration match will open the Games with a #BattleofWits, where every player has the chance to test their strategies, outsmart their opponents, and prove that anyone can rise to become a champion.
Chong added: “We’re incredibly proud that MCGG has reached international sporting stages, standing alongside both esports and traditional sports. Tournaments like the GO1 World Championship and the SEA Games give us the chance to uncover hidden champions—players whose talent and strategy might otherwise go unseen. Our goal has always been to empower everyday players through the game, and we’re excited to see our vision come to life on these big stages.”
Find out more about MCGG on the official website. Stay up to date by following MCGG’s social media channels, Facebook, Instagram, TikTok, YouTube, and X.
About Magic Chess: Go Go
Magic Chess: Go Go is a multiplayer mobile strategy game created by the original team from MOONTON Games’ star game, Mobile Legends: Bang Bang. The popular title has more than 30 million downloads and is available globally.

Hashtag: #MOONTONGames, #MCGG, #gaming, #mobilegaming


The issuer is solely responsible for the content of this announcement.

About MOONTON Games

Established in 2014, MOONTON Games is a global video game company dedicated to gaming development, publication, and esports. With more than 2,000 employees worldwide, the company operates offices in Indonesia, Malaysia, Singapore, the Philippines, Latin America, and China. It has successfully launched several high-profile mobile games globally and has built long-term relationships with governments and esports organizations in more than 30 countries around the world. Mobile Legends: Bang Bang is its current star game and the leading mobile multiplayer online battle arena (MOBA) game worldwide. For more information, visit https://en.moonton.com.

1...1,6331,6341,635...6,452Page 1,634 of 6,452